Joseph D Dekker

5PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cellular immunologyHaematological tumoursEvolution of developmental systemsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 20, 2026
An Integrin β6-targeted antibody-drug conjugate optimized for intravesical delivery to treat non-muscle invasive bladder cancer.

|Sep 13, 2024
Lymphoid origin of intrinsically activated plasmacytoid dendritic cells in mice.

Alessandra Machado Araujo, Joseph D Dekker, Kendra Garrison

|Oct 09, 2019
Loss of the FOXP1 Transcription Factor Leads to Deregulation of B Lymphocyte Development and Function at Multiple Stages.

Joseph D Dekker, Gisele V Baracho, Zilu Zhu

|Aug 15, 2018
Foxp2 regulates anatomical features that may be relevant for vocal behaviors and bipedal locomotion.

Shuqin Xu, Pei Liu, Yuanxing Chen

|Jul 17, 2018
Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme.

Todd A Triplett, Kendra C Garrison, Nicholas Marshall

Pageof 1

Frequent Collaborators

2 joint publications

Lauren I R Ehrlich

1 joint publications

Stefano Tiziani

1 joint publications

Simon E Fisher

1 joint publications

Gisele V Baracho